Kairos Pharma Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.57

+0.01 (+2.16%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,307.8% upside

Low Target $5.03

Average Target $8.04

High Target $9.33

Current Price $0.57

Current
$0.57

Target
$8.04

$5.03 $8.04 avg $9.33

Scenario Analysis

Bear Case

$5.03

780.8%

Low target

Base Case

$8.04

+1,307.8%

Avg target

Bull Case

$9.33

+1,533.7%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$2.11

-72.9% from high

52-Week Low

$0.40

+42.8% from low

Target vs 52W High

$8.04

+281.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%